David Chiang1, Xintong Chen2, Stacie M Jones3, Robert A Wood4, Scott H Sicherer1, A Wesley Burks5, Donald Y M Leung6, Charuta Agashe1, Alexander Grishin1, Peter Dawson7, Wendy F Davidson8, Leah Newman2, Robert Sebra2, Miriam Merad9, Hugh A Sampson1, Bojan Losic10, M Cecilia Berin11. 1. Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY. 2. Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY. 3. Department of Pediatrics, University of Arkansas for Medical Sciences and Arkansas Children's Hospital, Little Rock, Ark. 4. Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Md. 5. Department of Pediatrics, University of North Carolina, Chapel Hill, NC. 6. Department of Pediatrics, National Jewish Health, Denver, Colo. 7. EMMES Corporation, Rockville, Md. 8. National Institutes of Health (National Institute of Allergy and Infectious Diseases), Bethesda, Md. 9. Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY. 10. Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address: bojan.losic@mssm.edu. 11. Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address: cecilia.berin@mssm.edu.
Abstract
BACKGROUND: The contribution of phenotypic variation of peanut-specific T cells to clinical allergy or tolerance to peanut is not well understood. OBJECTIVES: Our objective was to comprehensively phenotype peanut-specific T cells in the peripheral blood of subjects with and without peanut allergy (PA). METHODS: We obtained samples from patients with PA, including a cohort undergoing baseline peanut challenges for an immunotherapy trial (Consortium of Food Allergy Research [CoFAR] 6). Subjects were confirmed as having PA, or if they passed a 1-g peanut challenge, they were termed high-threshold subjects. Healthy control (HC) subjects were also recruited. Peanut-responsive T cells were identified based on CD154 expression after 6 to 18 hours of stimulation with peanut extract. Cells were analyzed by using flow cytometry and single-cell RNA sequencing. RESULTS: Patients with PA had tissue- and follicle-homing peanut-responsive CD4+ T cells with a heterogeneous pattern of TH2 differentiation, whereas control subjects had undetectable T-cell responses to peanut. The PA group had a delayed and IL-2-dependent upregulation of CD154 on cells expressing regulatory T (Treg) cell markers, which was absent in HC or high-threshold subjects. Depletion of Treg cells enhanced cytokine production in HC subjects and patients with PA in vitro, but cytokines associated with highly differentiated TH2 cells were more resistant to Treg cell suppression in patients with PA. Analysis of gene expression by means of single-cell RNA sequencing identified T cells with highly correlated expression of IL4, IL5, IL9, IL13, and the IL-25 receptor IL17RB. CONCLUSIONS: These results demonstrate the presence of highly differentiated TH2 cells producing TH2-associated cytokines with functions beyond IgE class-switching in patients with PA. A multifunctional TH2 response was more evident than a Treg cell deficit among peanut-responsive T cells.
BACKGROUND: The contribution of phenotypic variation of peanut-specific T cells to clinical allergy or tolerance to peanut is not well understood. OBJECTIVES: Our objective was to comprehensively phenotype peanut-specific T cells in the peripheral blood of subjects with and without peanutallergy (PA). METHODS: We obtained samples from patients with PA, including a cohort undergoing baseline peanut challenges for an immunotherapy trial (Consortium of Food Allergy Research [CoFAR] 6). Subjects were confirmed as having PA, or if they passed a 1-g peanut challenge, they were termed high-threshold subjects. Healthy control (HC) subjects were also recruited. Peanut-responsive T cells were identified based on CD154 expression after 6 to 18 hours of stimulation with peanut extract. Cells were analyzed by using flow cytometry and single-cell RNA sequencing. RESULTS:Patients with PA had tissue- and follicle-homing peanut-responsive CD4+ T cells with a heterogeneous pattern of TH2 differentiation, whereas control subjects had undetectable T-cell responses to peanut. The PA group had a delayed and IL-2-dependent upregulation of CD154 on cells expressing regulatory T (Treg) cell markers, which was absent in HC or high-threshold subjects. Depletion of Treg cells enhanced cytokine production in HC subjects and patients with PA in vitro, but cytokines associated with highly differentiated TH2 cells were more resistant to Treg cell suppression in patients with PA. Analysis of gene expression by means of single-cell RNA sequencing identified T cells with highly correlated expression of IL4, IL5, IL9, IL13, and the IL-25 receptor IL17RB. CONCLUSIONS: These results demonstrate the presence of highly differentiated TH2 cells producing TH2-associated cytokines with functions beyond IgE class-switching in patients with PA. A multifunctional TH2 response was more evident than a Treg cell deficit among peanut-responsive T cells.
Authors: John F Ryan; Rachel Hovde; Jacob Glanville; Shu-Chen Lyu; Xuhuai Ji; Sheena Gupta; Robert J Tibshirani; David C Jay; Scott D Boyd; R Sharon Chinthrajah; Mark M Davis; Stephen J Galli; Holden T Maecker; Kari C Nadeau Journal: Proc Natl Acad Sci U S A Date: 2016-01-25 Impact factor: 11.205
Authors: Evan Z Macosko; Anindita Basu; Rahul Satija; James Nemesh; Karthik Shekhar; Melissa Goldman; Itay Tirosh; Allison R Bialas; Nolan Kamitaki; Emily M Martersteck; John J Trombetta; David A Weitz; Joshua R Sanes; Alex K Shalek; Aviv Regev; Steven A McCarroll Journal: Cell Date: 2015-05-21 Impact factor: 41.582
Authors: Alyssa Mitson-Salazar; Yuzhi Yin; Daniel L Wansley; Michael Young; Hyejeong Bolan; Sarah Arceo; Nancy Ho; Christopher Koh; Joshua D Milner; Kelly D Stone; Stephen A Wank; Calman Prussin Journal: J Allergy Clin Immunol Date: 2015-10-01 Impact factor: 10.793
Authors: Usriansyah Hadis; Benjamin Wahl; Olga Schulz; Matthias Hardtke-Wolenski; Angela Schippers; Norbert Wagner; Werner Müller; Tim Sparwasser; Reinhold Förster; Oliver Pabst Journal: Immunity Date: 2011-02-17 Impact factor: 31.745
Authors: Juan Manuel Leyva-Castillo; Pierre Hener; Paula Michea; Hajime Karasuyama; Susan Chan; Vassili Soumelis; Mei Li Journal: Nat Commun Date: 2013 Impact factor: 14.919
Authors: Antonio Scialdone; Kedar N Natarajan; Luis R Saraiva; Valentina Proserpio; Sarah A Teichmann; Oliver Stegle; John C Marioni; Florian Buettner Journal: Methods Date: 2015-07-02 Impact factor: 3.608
Authors: Bert Ruiter; Neal P Smith; Brinda Monian; Ang A Tu; Elizabeth Fleming; Yamini V Virkud; Sarita U Patil; Charles A Whittaker; J Christopher Love; Wayne G Shreffler Journal: J Allergy Clin Immunol Date: 2019-10-22 Impact factor: 10.793
Authors: Xiaoying Zhou; Wong Yu; Elizabeth D Mellins; Kari C Nadeau; Shu-Chen Lyu; Claudia Macaubas; Bryan Bunning; Ziyuan He Journal: J Exp Med Date: 2021-05-04 Impact factor: 14.307
Authors: Monali Manohar; Diane Dunham; Sheena Gupta; Zheng Yan; Wenming Zhang; Samantha Minnicozzi; Matthew Kirkey; Bryan Bunning; Roshni Roy Chowdhury; Stephen J Galli; Scott D Boyd; Laurie Elizabeth Kost; R Sharon Chinthrajah; Manisha Desai; Hans C Oettgen; Holden T Maecker; Wong Yu; Rosemarie H DeKruyff; Sandra Andorf; Kari C Nadeau Journal: Allergy Date: 2021-05-29 Impact factor: 14.710